🇯🇵 Wydase in Japan

PMDA authorised Wydase on 25 August 2021

Marketing authorisation

PMDA — authorised 25 August 2021

  • Marketing authorisation holder: Janssen Pharmaceutical, K.K.
  • Status: approved

Wydase in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Wydase approved in Japan?

Yes. PMDA authorised it on 25 August 2021.

Who is the marketing authorisation holder for Wydase in Japan?

Janssen Pharmaceutical, K.K. holds the Japanese marketing authorisation.